Market by Animal Type, Distribution Channel, Route of Administration, Product, and Country | Forecast 2019-2028
As per Triton's report, the European market for veterinary medicines is anticipated to garner a CAGR of 4.04% during the projected years 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market comprise:
•       The UK
•       Spain
•       Germany
•       Italy
•       France
•       Russia
•       Rest of Europe
In Germany, the surge in demand for veterinary medicines has resulted in the sanctioning of multiple new veterinary medicine products by the government. This further leads to the availability of new treatment routes, fueling the growth of the studied market. Moreover, animal health across the country is protected primarily by the legislation and veterinary administration. Furthermore, the country is witnessing a surge in antimicrobial resistance cases, which also heightens the need for veterinary medicines. Hence, the above-stated factors are contributing significantly to the development of the veterinary medicines market in Germany.
In France, cats are largely adopted as companion animals by the people. This growth in the adoption of companion animals has increased the demand for veterinary medicines. The French Agency for Veterinary Medicinal Products is considered the proficient authority for risk assessment and management relating to veterinary medicinal products. Furthermore, the surge in the occurrence of medical conditions has also increased the demand for veterinary medicines, motivating companies to launch new and innovative treatment options. These factors hold the potential to widen the scope and progress of the veterinary medicines market in France.
Boehringer Ingelheim Animal Health GmbH is one of the leading pharmaceutical companies involved in developing, producing, and marketing pharmaceutical products. The company provides prescription medicines in multiple segments, including animal health products. The animal health products primarily include biologicals and natural care products for cattle, horses, swine, and companion animals. It functions through its multiple business segments, such as animal health, biopharmaceuticals, industrial customers, and prescription medicines. The company has operations in several regions, with its headquarter in Germany.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   EUROPE VETERINARY MEDICINES MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1.  THREAT OF NEW ENTRANTS
2.2.2.  THREAT OF SUBSTITUTE PRODUCTS
2.2.3.  BARGAINING POWER OF BUYERS
2.2.4.  BARGAINING POWER OF SUPPLIERS
2.2.5.  THREAT OF COMPETITIVE RIVALRY
2.3. INDUSTRY COMPONENTS
2.4. LEGAL POLICY AND REGULATORY FRAMEWORK
2.5. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
2.6. MARKET ATTRACTIVENESS INDEX
2.7. KEY INSIGHT
2.8. MARKET DRIVERS
2.8.1.  RISE IN LIVESTOCK PRODUCTION
2.8.2.  SURGE IN VARIOUS MEDICAL CONDITIONS IN ANIMALS
2.8.3.  INCREASING OWNERSHIP OF PETS
2.9. MARKET RESTRAINTS
2.9.1.  ADVERSE EFFECTS OF POST-VACCINATION
2.9.2.  LACK OF ADEQUATE NUMBER OF VETERINARIANS
2.10. Â MARKET OPPORTUNITIES
2.10.1. GROWING ANIMAL HEALTHCARE EXPENDITURE
2.10.2. INCREASING DEMAND FOR VETERINARY SPECIALIZATION
2.11. MARKET CHALLENGES
2.11.1. STRINGENT REGULATIONS
2.11.2. HIGH COST OF ANIMAL VACCINES
3.   EUROPE VETERINARY MEDICINES MARKET OUTLOOK - BY ANIMAL TYPE
3.1. COMPANION ANIMALS
3.2. LIVESTOCK ANIMALS
4.   EUROPE VETERINARY MEDICINES MARKET OUTLOOK - BY DISTRIBUTION CHANNEL
4.1. RETAIL VETERINARY PHARMACIES
4.2. VETERINARY HOSPITAL PHARMACIES
5.   EUROPE VETERINARY MEDICINES MAREKT OUTLOOK - BY ROUTE OF ADMINISTRATION
5.1. PARENTERAL ROUTE
5.2. ORAL ROUTE
5.3. TOPICAL ROUTE
6.   EUROPE VETERINARY MEDICINES MARKET OUTLOOK - BY PRODUCT
6.1. DRUGS
6.1.1.  ANTI-INFECTIVE
6.1.2.  ANTI-INFLAMMATORY
6.1.3.  PARASITICIDE
6.2. VACCINES
6.2.1.  INACTIVATED VACCINES
6.2.2.  ATTENUATED VACCINES
6.2.3.  RECOMBINANT VACCINES
6.3. MEDICATED FEED ADDITIVES
6.3.1.  ANTIBIOTICS
6.3.2.  AMINO ACIDS
7.   GEOGRAPHICAL ANALYSIS - EUROPE
7.1. COUNTRY ANALYSIS
7.1.1.  GERMANY
7.1.2.  FRANCE
7.1.3.  UNITED KINGDOM
7.1.4.  ITALY
7.1.5.  RUSSIA
7.1.6.  SPAIN
7.1.7.  REST OF EUROPE
8.   COMPANY PROFILES
8.1. EVONIK INDUSTRIES AG (RAG STIFTUNG)
8.2. INDIAN IMMUNOLOGICALS LIMITED
8.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
8.4. MERCK & CO
8.5. ZOETIS
8.6. BIOGENESIS BAGO SA
8.7. VETOQUINOL (SOPARFIN SCA)
8.8. ARCHER DANIELS MIDLAND
8.9. CEVA SANTE ANIMALE
8.10. VIRBAC SA
8.11.  DECHRA PHARMACEUTICALS PLC
8.12. NEOGEN CORPORATION
8.13. ELANCO
8.14.  HESTER BIOSCIENCES LIMITED
8.15.  KINDRED BIOSCIENCES
9.   RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1.  OBJECTIVES OF STUDY
9.1.2.  SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1.  PRIMARY DATA SOURCES
9.2.2.  SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1.  EVALUATION OF PROPOSED MARKET
9.3.2.  IDENTIFICATION OF DATA SOURCES
9.3.3.  ASSESSMENT OF MARKET DETERMINANTS
9.3.4.  DATA COLLECTION
9.3.5.  DATA VALIDATION & ANALYSIS
TABLE 1: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: EUROPE VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)
TABLE 3: EUROPE VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 4: EUROPE VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)
TABLE 5: EUROPE VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 6: EUROPE DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 7: EUROPE VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 8: EUROPE MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 9: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)Â Â Â Â Â Â
FIGURE 1: EUROPE VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 2: EUROPE VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 3: EUROPE VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)
FIGURE 4: EUROPE VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 5: EUROPE VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 6: EUROPE VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 7: EUROPE VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 8: EUROPE VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)
FIGURE 9: EUROPE VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)
FIGURE 10: EUROPE DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)
FIGURE 11: EUROPE DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)
FIGURE 12: EUROPE DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)
FIGURE 13: EUROPE VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 14: EUROPE VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 15: EUROPE VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 16: EUROPE VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 17: EUROPE VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)
FIGURE 18: EUROPE MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)
FIGURE 19: EUROPE MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)
FIGURE 20: GERMANY VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 21: FRANCE VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 22: UNITED KINGDOM VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 23: ITALY VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)
FIGURE 24: RUSSIA VETERINARY VACCINE MARKET 2019-2028 (IN $ MILLION)
FIGURE 25: SPAIN VETERINARY VACCINE MARKET 2019-2028 (IN $ MILLION)
FIGURE 26: REST OF EUROPE VETERINARY VACCINE MARKET 2019-2028 (IN $ MILLION)